Editing HBM Healthcare Investments
The edit can be undone. Please check the comparison below to verify that this is what you want to do, and then publish the changes below to finish undoing the edit.
Latest revision | Your text | ||
Line 351: | Line 351: | ||
'''Exhibit 11: NAV performance versus MSCI World Health Care Index over five years'''<ref>Source: Refinitiv, Edison Investment Research.</ref> | '''Exhibit 11: NAV performance versus MSCI World Health Care Index over five years'''<ref>Source: Refinitiv, Edison Investment Research.</ref> | ||
As shown in Exhibits 10 and 11, the past 12 months have been a more difficult period of relative performance versus the broad healthcare equity market and the MSCI World Index, although HBMN’s longer-term performance record versus all comparator indices remains compelling in both share price and NAV terms. | As shown in Exhibits 10 and 11, the past 12 months have been a more difficult period of relative performance versus the broad healthcare equity market and the MSCI World Index, although HBMN’s longer-term performance record versus all comparator indices remains compelling in both share price and NAV terms. |